UCLA Today News Logo

:: UCLA TODAY Home

:: Contact Us
Search Archive
:: UCLA HOME

 

 

 

©2004
The Regents of the University of California
 

 
VOL. 25. NO.4 OCTOBER 26, 2004

Campus health centers cope with flu shot shortage

by ajay singh
ucla today staff

Halloween’s around the corner, ushering in the holiday season. But this festive period is also when the flu season kicks in, and this time it will be complicated by the national shortage of flu vaccine that is unlikely to be resolved by the end of the year.

Flu season begins in late November or early December and continues until early March, causing some 36,000 deaths and 200,000 hospitalizations annually, according to the Centers for Disease Control and Prevention (CDC). But those who aren’t at a high risk of serious complications from influenza, even nurses and doctors who work with patients, will have to wait for their shots, said J. Thomas Rosenthal, chief medical officer for UCLA Healthcare.

Following CDC guidelines, the campus health system — including the Arthur Ashe Student Health and Wellness Center — has set aside vaccines only for those considered to be at significant risk if they catch the flu. These individuals include all children 6 months to 23 months old; adults aged 65 years or older; children and adults with chronic health problems such as lung disease, blood disorders, coronary disease, diabetes and weakened immune systems; children and teenagers 6 months to 18 years old undergoing chronic aspirin therapy (an aspirin a day); and all women who are pregnant during the flu season.

October through November is the best time to get vaccinated, according to the CDC, because the flu season peaks anywhere from late December to early March, and it takes some two weeks after vaccination for antibodies to develop. If the flu season peaks late, getting vaccinated in December or later can still help.

The reason for the vaccine shortage has been widely reported: Citing quality control problems, British authorities earlier this month shut down the plant of Chiron Corporation, a major flu vaccine manufacturer that supplies nearly half of the 100 million doses used annually in the United States.

“Nobody could have predicted this would have happened,” said Rosenthal, adding that UC San Francisco and UC Davis are both experiencing an extreme shortfall because they ordered from the British company. “We were fortunate that we ordered from a [U.S.] company that was not shut down,” he said.

In fact, the medical center has approximately the same amount of vaccine it received in previous years. “The problem is that demand has been higher than in previous years,” explained Rosenthal. “I wouldn’t call it a scare or hysteria, but there has been great publicity in the press about the shortage, causing people to wait in lines outside pharmacies.”

The vaccine shortage is unlikely to be resolved by the end of the year, said Rosenthal, which means that many people will have to wait until 2005 to get their shots. However, “the company that supplies UCLA has been trying to make efforts to increase supplies to Los Angeles County and other counties around the country,” Rosenthal added.

For news updates on the availability of vaccine and advice on how to keep from getting the flu, visit the Centers for Disease Control Web site: www.cdc.gov/flu.